COMPOSITIONS AND METHODS FOR TREATING MYASTHENIA GRAVIS
Applicants:
- NMD PHARMA AS [NORA names: Other Companies; Private Research]
Abstract
Disclosed herein are methods of treatment for myasthenia gravis (MG) that involve administering (2S)-2-[4-bromo-2-(1,2-oxazol-3-yl)phenoxy]propanoic acid, or a pharmaceutical composition thereof, to a patient suffering from symptoms of MG. Pharmaceutical compositions and kits-to-parts including (2S)-2-[4-bromo-2-(1,2-oxazol-3-yl)phenoxy]propanoic acid are also disclosed.
Patent Family Records (1)
COMPOSITIONS AND METHODS FOR TREATING MYASTHENIA GRAVIS
NMD PHARMA AS PEDERSEN THOMAS HOLM, BOLD JANE MARY, GRØNNEBÆK THOMAS SKJÆRLUND, (...more)
2024, WO-2024068862-A1